The significance of a positive DAT in thalassemia patients
Paid access
|Mar 2020Authors
S.A. Arinsburg
New York Blood Center/New York Presbyterian Hospital, Columbia University Medical Center, Department of Professional Education, New York, NY, United States
D.L. Skerrett
Transfusion Medicine and Cellular Therapy, New York, NY, United States
D. Kleinert
Nurse Practitioner, Thalassemia Program, New York, NY, United States
P.J. Giardina
Thalassemia Program, Transfusion Medicine and Cellular Therapy, New York-Presbyterian Hospital-Weill Cornell Medical College, Department of Pathology, New York, NY, United States
M.M. Cushing
Thalassemia Program, Transfusion Medicine and Cellular Therapy, New York-Presbyterian Hospital-Weill Cornell Medical College, Department of Pathology, New York, NY, United States
DOI: https://doi.org/10.21307/immunohematology-2019-207 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 87 - 91
Published on: Mar 14, 2020
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2020 S.A. Arinsburg, D.L. Skerrett, D. Kleinert, P.J. Giardina, M.M. Cushing, published by American National Red Cross
This work is licensed under the Creative Commons License.